Press Release | December 5, 2019 | Biotechnology Innovation Organization (BIO), Human Health, Policy & Regulatory, Reimbursement & Access, Cost & Value of Biopharmaceuticals
More than 135 Emerging Biotech Leaders Urge Congress to Reject H.R. 3
“Our continued success depends on maintaining an environment that supports investment in tomorrow’s discoveries.”
Washington, DC: December 5, 2019 – In a letter addressed to House Speaker Nancy Pelosi (D-CA) and House…